| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |